Your browser doesn't support javascript.
loading
Post-prandial lipid effects of raltegravir versus darunavir/ritonavir in HIV-1-infected adults commencing combination ART.
Lee, F J; Marriott, D; Bloch, M; Richardson, R; Mackenzie, N; Carr, A.
Afiliação
  • Lee FJ; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia frederick.lee@sswahs.nsw.gov.au.
  • Marriott D; HIV, Immunology and Infectious Diseases Unit, St Vincent's Hospital, Sydney, Australia.
  • Bloch M; Holdsworth House Medical Practice, Sydney, Australia.
  • Richardson R; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.
  • Mackenzie N; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.
  • Carr A; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia HIV, Immunology and Infectious Diseases Unit, St Vincent's Hospital, Sydney, Australia.
J Antimicrob Chemother ; 71(4): 1127-9, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26682962
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Ritonavir / Fármacos Anti-HIV / Metabolismo dos Lipídeos / Darunavir / Raltegravir Potássico Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Ritonavir / Fármacos Anti-HIV / Metabolismo dos Lipídeos / Darunavir / Raltegravir Potássico Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article